Canada Syphilis Testing Market Insight
Published: 18 May 2026 | Report Format: Electronic (PDF)
The Canada syphilis testing market size is growing at a 6.21% CAGR, driven by the increasingly integrating rapid diagnostic tests, molecular testing platforms, immunoassays, and point-of-care screening technologies.
Canada Syphilis Testing Market Insights Forecasts to 2035
- The Canada Syphilis Testing Market Size Was Estimated at USD 64.7 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.21% from 2025 to 2035
- The Canada Syphilis Testing Market Size is Expected to Reach USD 118.2 Million by 2035
Notable Insights for Canada Syphilis Testing Market
- By test type, rapid diagnostic tests occupied almost 34-35% of the Canada syphilis testing market share in 2025 due to growing popularity among consumers regarding the availability of fast and easy sexually transmitted infection tests.
- By technology, laboratory-based syphilis testing accounted for about 58-60% market share in 2025 due to high demand for accurate diagnostics equipment in hospitals and clinics across the country.
- Health Canada monitors diagnostic equipment for the treatment of medical conditions, infectious disease testing systems, and laboratory screening products through regulatory healthcare policies, which guarantee the highest quality standards in syphilis testing services across Canada.
- Public Health Agency of Canada supports sexually transmitted infection awareness, national disease tracking programs, and prevention measures to enhance public health efforts and provide more syphilis testing and diagnosis services.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Canada syphilis testing market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment Market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the Market.
Top Companies in Canada Syphilis Testing Market
-
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Trinity Biotech plc
- OraSure Technologies, Inc.
- Hologic, Inc.
recent Developments:
- In August 2025, Health Canada strengthened the Canada syphilis testing market by approving MedMira’s Reveal TP rapid test, supported by clinical studies involving 1,760 participants, accelerating point-of-care STI screening accessibility nationwide.
- In February 2024, the Canada syphilis testing market gained momentum after the Public Health Agency of Canada announced CAD 2.45 million funding to expand rapid syphilis screening, automated laboratory diagnostics, and nationwide STI testing accessibility.
Market Segmentation:
Canada Syphilis Testing Market, By Test Type
-
- Rapid Tests
- ELISA Tests
- PCR Tests
- VDRL Tests
- RPR Tests
- Others
Canada Syphilis Testing Market, By Technology
-
- Laboratory-Based Testing
- Point-of-Care Testing
Canada Syphilis Testing Market, By Application
-
- Hospitals
- Diagnostic Laboratories
- Public Health Programs
- Others
Canada Syphilis Testing Market, By End User
-
- Hospitals
- Clinics
- Diagnostic Centers
- Research Institutes
- Others
Expert Views:
The Canada syphilis testing market is forecast to experience strong long-term growth due to increased health awareness, initiatives for infectious disease testing, and breakthroughs in diagnostic technologies that are changing the Canadian sexual health care environment. Increasing demands for easy access to STI tests, disease diagnosis, and automation of diagnostic testing processes will likely fuel the market growth.